Regulatory approvals – what the announcement says
The press release that announced the transaction states only that “CommScope has entered into a definitive agreement to sell its Connectivity and Cable Solutions segment to Amphenol.”
The release does not list any specific regulatory approvals that must be obtained for the transaction.
Typical approvals for a deal of this size (although they are not mentioned in the announcement) normally include:
| Typical approval | Why it is often required | Typical regulator(s) |
|---|---|---|
| U.S. antitrust (Hart‑Scott‑Rodino) filing | To ensure the transaction does not substantially lessen competition in the telecom‑infrastructure market. | U.S. Department of Justice (DOJ) / Federal Trade Commission (FTC). |
| Foreign‑investment review (if any foreign investors are involved) | To protect national security and ensure compliance with the Foreign Investment Risk Review (FIRR) or similar statutes. | Committee on Foreign Investment in the United States (CFIUS) or similar agency. |
| Sector‑specific approvals (e.g., FCC, FCC‑related equipment certifications) | If the assets include regulated telecommunications equipment. | Federal Communications Commission (FCC) or other industry‑specific bodies. |
| State‑level antitrust reviews | Some states require separate filings for large M&A. | State attorney general offices or state‑level competition agencies. |
| Shareholder/board approvals | Required under corporate governance rules. | Not a regulatory agency, but a mandatory corporate step. |
| Other contractual or regulatory consents (e.g., lease assignments, licensing agreements) | May be required to transfer existing contracts. | Relevant contract counterparties or regulatory bodies that issued the original licenses. |
Because the press release does not specify which of these, if any, have been identified for this transaction, we cannot confirm exactly which approvals will be required. It is standard practice for a transaction of roughly $10.5 billion to require at least the U.S. antitrust review, and often other approvals as noted above.
Timeline for closing – what the announcement says
The news release provides the transaction date (the agreement was signed on August 4, 2025) and states that the parties have entered into a “definitive agreement.” The release does not contain:
- A specific closing date (e.g., “closing expected in Q4 2025”).
- A timeline for any required regulatory or shareholder approvals.
- Any mention of a “closing period,” “expected close by” date, or “subject to customary closing conditions” beyond the standard “subject to regulatory approvals and other customary closing conditions” language that is typical in such announcements (but which is not explicitly quoted in the excerpt you provided).
Therefore, based on the information available in the news excerpt, the exact timeline for closing the deal is not disclosed.
Summary
- Regulatory approvals required: Not specified in the news release. Typical deals of this size normally require U.S. antitrust review (and possibly other sector‑specific or foreign‑investment approvals) and any required shareholder or board approvals.
- Timeline for closing: The news article does not provide a specific closing date or timeline; it only announces that a definitive agreement has been signed on August 4 2025. Further details will likely be disclosed in later filings (e.g., Form 8‑K or a later press release) once the parties have clarified the required regulatory clearances and the expected closing schedule.